Skip to content
Open access

Racial and Ethnic Disparities in Access to Home‐Based Renal Replacement Therapies Among Incident End‐Stage Renal Disease Patients in the United States

Oct 2026 · Seminars in dialysis · Vol 39, pp. 266 - 278 · 0 citations · 26 references
Medicine

TL;DR

Evaluation of racial and ethnic disparities in the initial modality of RRT among incident adult ESRD patients in the United Stated from 2014 to 2020 found inequities at treatment initiation persist.

Abstract

Racial and ethnic disparities in access to home‐based renal replacement therapies (RRT) remain a major concern in the management of end‐stage renal disease (ESRD) in the United States. Despite national efforts to expand home hemodialysis (HHD) and peritoneal dialysis (PD), inequities at treatment initiation persist. Therefore, the goal was to evaluate racial and ethnic disparities in the initial modality of RRT among incident adult ESRD patients in the United Stated from 2014 to 2020.

Read PDF

Similar papers

Open access Oct 2026

Equity Gaps in Sex, Racial, and Ethnic Inclusion in United States Heart Transplant Trials

Heart transplantation (HT) remains the definitive therapy for select patients with end‐stage heart failure but the extent of sex, racial, and ethnic inclusion in U.S. HT clinical trials has not been systematically evaluated at the level of clinical trials.

A. Manasrah, K. Sporn, Shahed Manasrah et al. · 0 citations
Open access Oct 2026

Racial Disparities in Kidney Failure Among Black People in Ontario: A Population-Based Study

Ontario recently designated Black people aged 40 and older as a high-risk group for annual chronic kidney disease (CKD) screening in primary care, yet population-level data have been limited. To describe and compare kidney failure incidence, prevalence, pre-dialysis care, treatment modality, and mortality be...

Laura Seliske, Jane Ip, Devron J. Swaby et al. · 0 citations
Oct 2026

Association of Medicare's ESRD Treatment Choices Model with Timely Access to Kidney Transplantation in the Southeastern United States.

BACKGROUND In 2021, Medicare's End-Stage Renal Disease Treatment Choices (ETC) Model randomly assigned 30% of U.S. dialysis facilities to financial incentives to increase home dialysis, waitlisting, and living-donor kidney transplantation. Early evaluations found no improvements in waitlisting or transplantation, but w...

K. Drewry, Kristopher M. Huffman, Daeho Kim et al. · 0 citations
Open access Oct 2026

Improving Access to Transplant: A Quality Improvement Initiative to Reduce Time From Outpatient Dialysis Initiation to Deceased Donor Kidney Transplant Activation

Pre‐emptive kidney transplantation is the preferred treatment in patients with end‐stage kidney disease (ESKD); however, many patients must unavoidably initiate dialysis prior to transplantation. Prolonged dialysis exposure is associated with increased morbidity and mortality, mandating prompt transition to transplant...

Priyanka Chati, Jessica Whittington, Karissa Braden et al. · 0 citations
Review Open access Sep 2026

Efficacy and Safety of Incremental Hemodialysis: A Systematic Review and Meta‐Analysis

Hemodialysis, the most commonly employed renal replacement therapy in end‐stage kidney disease, prescriptions have long been standardized as thrice‐weekly at full‐dose; however, HD implementation is not without major complications. Incremental HD modalities are developed to face such one‐size‐fits‐all approach with hop...

Berk Mızrak, Sidar Çopur, F. Casino et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.